Order:
  1.  36
    Archmedes in the lab: Can science identify good moral reasoning?Regina Rini & Tommaso Bruni - 2017 - In Jean-François Bonnefon & Bastien Trémolière, Moral Inferences. New York, NY: Routledge. pp. 155-169.
    Some ethicists try to settle moral disagreement by ruling out particular types of moral reasoning on the basis of cognitive scientific evidence. We argue that the cognitive science of reasoning is not well-suited to this Archimedean role. Through discussion of several influential research programs, we show that such attempts tend to either fail to be Archimedean (by assuming controversial moral views) or fail to settle disagreement (by getting caught up in unsettled debates about rationality). We speculate that these outcomes reflect (...)
    Download  
     
    Export citation  
     
    Bookmark  
  2. Ethical considerations in functional magnetic resonance imaging research in acutely comatose patients.Charles Weijer, Tommaso Bruni, Teneille Gofton, G. Bryan Young, Loretta Norton, Andrew Peterson & Adrian M. Owen - 2015 - Brain:0-0.
    After severe brain injury, one of the key challenges for medical doctors is to determine the patient’s prognosis. Who will do well? Who will not do well? Physicians need to know this, and families need to do this too, to address choices regarding the continuation of life supporting therapies. However, current prognostication methods are insufficient to provide a reliable prognosis. -/- Functional Magnetic Resonance Imaging (MRI) holds considerable promise for improving the accuracy of prognosis in acute brain injury patients. Nonetheless, (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  3. Cystic fibrosis carrier screening in Veneto (Italy): an ethical analysis. [REVIEW]Tommaso Bruni, Matteo Mameli, Gabriella Pravettoni & Giovanni Boniolo - 2012 - Medicine, Health Care and Philosophy 15 (3):321-328.
    A recent study by Castellani et al. (JAMA 302(23):2573–2579, 2009) describes the population-level effects of the choices of individuals who underwent molecular carrier screening for cystic fibrosis (CF) in Veneto, in the northeastern part of Italy, between 1993 and 2007. We discuss some of the ethical issues raised by the policies and individual choices that are the subject of this study. In particular, (1) we discuss the ethical issues raised by the acquisition of genetic information through antenatal carrier testing; (2) (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation